BAYER AKTIENGESELLSCHAFT
Kaiser-Wilhelm-Allee 1 – Leverkusen – 51373
VAT: DE123659859
http://www.bayerpharma.de
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, BAYER AKTIENGESELLSCHAFT has received € 0.0 for its participation in a total of 7 project(s) with a total cost of € 209,402,815.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-01 | 2024-08-31 | 831458 | Trials@Home | participant | € 0.0 | € 39,148,297 | 1 | 33 | CORDIS ↪ | |
| 2019-04-01 | 2024-03-31 | 820820 | MOBILISE-D | drug discovery · multiple sclerosis · sensors · health care services · cardiology | participant | € 0.0 | € 49,911,564 | 2 | 38 | CORDIS ↪ |
| 2020-01-01 | 2022-12-31 | 853992 | PharmaLedger | governance · big data · cryptography · business intelligence · health care services | participant | € 0.0 | € 22,118,324 | 2 | 30 | CORDIS ↪ |
| 2020-11-01 | 2025-10-31 | 945473 | ARDAT | drug safety · gene therapy · immunology · genomes · cells technologies | participant | € 0.0 | € 25,490,491 | 1 | 34 | CORDIS ↪ |
| 2018-05-01 | 2023-10-31 | 777492 | PIONEER | prostate cancer · big data | participant | € 0.0 | € 13,549,159 | 1 | 38 | CORDIS ↪ |
| 2019-03-01 | 2025-08-31 | 821558 | IMMUcan | databases · oncology · immunotherapy · microbiology | participant | € 0.0 | € 35,779,304 | 1 | 31 | CORDIS ↪ |
| 2018-04-01 | 2023-03-31 | 777500 | IMI-PainCare | drug discovery · surgery · pharmaceutical drugs · pathophysiology · pharmacokinetics | participant | € 0.0 | € 23,405,673 | 1 | 41 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, BAYER AKTIENGESELLSCHAFT has received € 7,500.0 for its participation in a total of 1 project(s) with a total cost of € 6,996,623.
BAYER AKTIENGESELLSCHAFT did not participate in complicit projects under FP7 (2007-2013).